The global demand for Allergy Therapeutics Market is presumed to reach the market size of nearly USD 40.54 BN by 2030 from USD 22.9 BN in 2022 with a CAGR of 7.4% under the study period 2023 - 2030.
Allergy therapeutics, also known as allergy immunotherapy or allergy shots, are medical treatments designed to help individuals with allergies build a tolerance to specific allergens (substances that trigger allergic reactions). Allergy is an immune system response to normally harmless substances like pollen, dust mites, pet dander, or certain foods. This can lead to sneezing, itching, congestion, hives, or even severe allergic reactions in some cases.
Market Dynamics
The increasing prevalence of allergies worldwide, including conditions like allergic rhinitis, asthma, and food allergies, is positively affecting the market growth. Lifestyle changes, urbanization, and exposure to environmental allergens contribute to this trend, prompting individuals to seek effective allergy management solutions. Advancements in treatment modalities, including innovative options like sublingual immunotherapy (SLIT) tablets, offer patients more convenient and personalized alternatives to traditional allergy shots. Additionally, heightened patient awareness and education about allergies, coupled with improved healthcare infrastructure and access to specialized care, have led to greater demand for allergy therapeutics. Technological advancements in allergy testing, government initiatives promoting effective allergy management, and the recognition of occupational allergies further bolster the market. The rise in food allergies, global travel, and the need for insect venom allergy treatments also contribute to market growth. Ongoing research, clinical trials, and collaborations between pharmaceutical companies and academic institutions are driving the development of new and improved allergy therapeutics. As allergies continue to impact public health and well-being, the market is expected to expand, providing individuals with more effective and personalized options for allergy management.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of allergy therapeutics. The growth and trends of allergy therapeutics industry provide a holistic approach to this study.
Market Segmentation
This section of the allergy therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Treatment Type
- Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs)
- Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT))
By Type
- Eye Allergy
- Asthma
- Skin Allergy
- Food Allergies
- Rhinitis
- Other Allergy Types
By Route Of Administration
- Oral
- Inhalers
- Intranasal
- Other Routes Of Administration
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channels
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Allergy Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Allergy Therapeutics Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Allergy Therapeutics market include Allergopharma, Danaher, AbbVie Inc., Allergy Therapeutics plc, Sanofi SA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Merck & Co., Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.